Journals / Türk Kardiyoloji Derneği Arşivi / 2004 / Cilt: 32 - Sayı: 5

Dilate kardiyomiyopatili hastalarda angiotensin dönüştürücü enzim, angiotensin II reseptör, apolipoprotein E ve endotelyal konstitütif nitrik oksit sentaz geri polimorfizmi

Angiotensin-converting enzyme, angiotensin II receptor, apolipoprotein E and endothelial constitutive nitric oxide synthase gene polymorphisms in dilated cardiomyopathy

Pages
295–301
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

All patients wereassessed by 2-dimensional echocardiography and all had left ventriculardilatation (end diastolic diameter >55 mm) and impaired systolic function(ejection fraction

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Genetic factors are hypothesized to contribute to the dilated cardiomyopathy(DCM) susceptibility, even in sporadic cases.
📊
Key Findings & Data:The aim of the present study is to assess the effect offour candidate gene polymorphisms (1166 A/C polymorphism of the angiotensinII type 1 receptor (AGTR1) gene, I/D polymorphism of angiotensin convertingenzyme (ACE) gene, endothelial nitric oxide synthase (ec-NOS) and apolipoproteinE (APOE genes) on the pathogenesis of dilated cardiomyopathy.
💡
Conclusion & Impact:All patients wereassessed by 2-dimensional echocardiography and all had left ventriculardilatation (end diastolic diameter >55 mm) and impaired systolic function(ejection fraction
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Genetic factors are hypothesized to contribute to the dilated cardiomyopathy(DCM) susceptibility, even in sporadic cases. Abundant reports have investigated the association between various gene polymorphisms and the phenotypicexpression of DCM. The aim of the present study is to assess the effect offour candidate gene polymorphisms (1166 A/C polymorphism of the angiotensinII type 1 receptor (AGTR1) gene, I/D polymorphism of angiotensin convertingenzyme (ACE) gene, endothelial nitric oxide synthase (ec-NOS) and apolipoproteinE (APOE genes) on the pathogenesis of dilated cardiomyopathy. We studied 76 consecutive patients (mean age 58±12) with DCM and 88 healthyage- and sex-matched control subjects (mean age 59±12). All patients wereassessed by 2-dimensional echocardiography and all had left ventriculardilatation (end diastolic diameter >55 mm) and impaired systolic function(ejection fraction

Özet

Amaç: Dilate kardiyomiyopati (DCM) sol yada her iki ventrikülün sistolikfonksiyonlarının bozulması ve genişlemesi ile karakterize bir hastalıktır.Ailesel kökenli DCM'nin tanımlanmasından sonra ailesel olmayan DCM olgularıiçin de genetik faktörlerin rol oynayabileceği düşünülmüş ve konuyla ilgiliaraştırmalar yapılmıştır. Makalemizde ülkemizde yaşayan DCM'li olgularda,hastalığın patofizyolojisinde rol oynaması muhtemel dörtaday genin polimorfizmleri araştırılmıştır (Angiotensin dönüştürücü enzim(ACE) I/D polimorfizmi, angiotensin II reseptör (AGTR1) 1166 A/C polimorfizmi,apolipoprotein E (APOE) ve endotelyal konstitütif nitrik oksit sentaz (ecNOS)geni polimorfizmi).Ortalama yaşı 58±12 olan ardışık 76 hasta ve yaş ortalaması 59±12 olan 88 kontrolgrubu çalışmaya alındı. Bütün hastalara ve kontrol grubuna ekokardiyografikçalışma yapıldı. DCM tanısı için ekokardiyografik olarak end-diastolik çapın>55mm ve ejeksiyon fraksiyonunun

🔖

Cite This Article

KAYA, G., ÖZHAN, H., AKDEMİR, R., ERBİLEN, E., ZUNGUR, M., YAZICI, M., ALBAYRAK, S., MUTLU, H., KARA, İ., UYAN, C., GÜNDÜZ, H. (2022). Dilate kardiyomiyopatili hastalarda angiotensin dönüştürücü enzim, angiotensin II reseptör, apolipoprotein E ve endotelyal konstitütif nitrik oksit sentaz geri polimorfizmi. Türk Kardiyoloji Derneği Arşivi, Cilt: 32 - Sayı: 5, 295–301. https://ajindex.com/articles/633792

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Richardson P, McKenna W, Bristow M et al: Report of the 1995 WHO/ISFC Task Force on the Definition and Classification of Cardiomyopathies. Circulation 1996
  2. 2 2. Montgomery H, Keelinga PJ, Goldmana JH, Humphri- esb SE, Talmudb PJ, McKennaa WC: Lack of Association Between the Insertion/Deletion Polymorphism of the An- giotensin-Converting Enzyme Gene and Idiopathic Dilated Cardiomyopathy. JACC 1995
  3. 31 3. Tiret L, Mallet C, Poirier O, et al: Lack of association between polymorphisms of eight candidate genes and idio¬ pathic dilated cardiomyopathy. The CARDIGENE study JACC 2000
  4. 35 4. Charron P, Tesson F, Poirier O et al: Identification of a genetic risk factor for idiopathic dilated cardiomyopathy. Involvement of a polymorphism in the endothelin receptor type A gene. CARDIGENE group. Eur Heart J 1999
  5. 91 5. Rigat B, Hubert C, Alhenc F, Cambien F, Corvol P, So- ubrier F: An insertion /deletion polymorphism in angioten- sin I-converting enzyme gene accounting for half the vari- ence of serum enzyme levels. J Clin Invest 1990
  6. 46 6. Danser AHJ, Schalekamp MADH, Box WA, et al: An- giotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation 1995
  7. 88 7. Cambien F, Pourier O, Lecerf L, et al: Deletion poly- morphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992:259:641-4 8 Schunkert H, Hense HW, Holmer SR, et al: Association between a deletion polymorphyism of the angiotensin converting enzyme gene and left ventricular hypertrophy. NEngJMedl994
  8. 8 9 Marian AJ, Yu Q, Workman R, Greve G, Roberts R: Angiotensin converting enzyme polymorphyism in hypert- rophic cardi_____amyopathy and sudden cardiac death. Lancet 1993
  9. 6 10. Raynolds MV, Bristow MR, Bush EW, et al: Angio- tensin converting enzyme DD genotype in patients with isehemic or idiopathic dilated cardiomyopathy. Lancet 1993
  10. 5 11. Sanderson JE, Young YP, Yu CM, Chan S, Critchley JAJH, Woo KS: Lack of association between insertion/de- letion polymorhism of the angiotensin-converting enzyme gene and end-stage heart failure due to isehemic or idio- pathic dilated cardiomyopathy in the Chinese. Am J Cardi- oll996
  11. 10 12. Asano K, Dutcher DL, Port JD et al: Selective downre- gulation of the angiotensin II ATI-receptor subtype in fai- ling human ventricular myocardium. Circulation 1997
  12. 1200 12. Tiret L, Bonnardeaux X,